文献速递骨质疏松与钙磷/甲状旁腺肥胖与代谢综合征

波士顿STOP IT试验中试验期间平均25(OH)D和PTH水平与老年男女跌倒风险的关系

Intra-trial Mean 25(OH)D and PTH Levels and Risk of Falling in Older Men and Women in the Boston STOP IT Trial.
PubMed 文献 · J Clin Endocrinol Metab · 2022-01-01

该研究在410名年龄≥65岁、参与为期3年波士顿STOP IT试验的男女中,观察性分析试验期间平均25(OH)D和PTH水平与首次跌倒的关系。结果显示试验期间平均25(OH)D与跌倒风险呈U型关联,最低风险范围约为20至40 ng/mL;PTH与跌倒风险无显著关联。

要点

  • 试验期间平均25(OH)D与跌倒风险呈U型关联,最低风险范围约20至40 ng/mL。
  • PTH与跌倒风险无显著关联。
  • 作者认为维持循环25(OH)D在20至40 ng/mL很重要,该范围也是骨骼健康推荐范围。

核心结论

  • 试验期间平均25(OH)D与跌倒风险呈U型关联,最低风险范围约20至40 ng/mL,该范围也是骨骼健康推荐范围。
  • 在正常范围内的PTH水平下,未检测到PTH与跌倒风险的独立关联。

研究设计与样本

  • 在临床试验内进行的观察性分析,对象为参与为期3年波士顿STOP IT试验的410名年龄≥65岁男女。
  • 该试验旨在确定补充700 IU维生素D3加钙对跌倒发生(次要终点)的影响。
  • 试验期间25(OH)D和PTH暴露值计算为截至并包括首次跌倒前每半年一次测量的平均值。

主要发现

  • 试验期间平均25(OH)D与跌倒风险呈U型关联,最低风险范围约20至40 ng/mL。
  • PTH与跌倒风险无显著关联。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Supplementation with vitamin D has the potential to both reduce and increase risk of falling, and parathyroid hormone (PTH) may contribute to fall risk. OBJECTIVE: To assess the associations of intra-trial mean circulating levels of 25-hydroxyvitamin D [25(OH)D] and PTH on incident falls in healthy older adults. DESIGN: Observational within a clinical trial. SETTING: The Bone Metabolism Laboratory at the USDA Nutrition Center at Tufts University. PARTICIPANTS: 410 men and women age ≥65 years who participated in the 3-year Boston STOP IT trial to determine the effect of supplementation with 700 IU of vitamin D3 plus calcium on incident falls (secondary endpoint). Intra-trial exposures of 25(OH)D and PTH were calculated as the mean of biannual measures up to and including the first fall. MAIN OUTCOME MEASURES: Incidence of first fall. RESULTS: Intra-trial mean 25(OH)D was significantly associated with risk of falling in a U-shaped pattern; the range associated with minimal risk of falling was approximately 20 to 40 ng/mL. PTH was not significantly associated with risk of falling. CONCLUSIONS: The findings highlight the importance of maintaining the circulating 25(OH)D level between 20 and 40 ng/mL, the range that is also recommended for bone health. At PTH levels within the normal range, there was no detectible independent association of PTH with fall risk.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Dawson-Hughes B, Wang J, Barger K, et al. Intra-trial Mean 25(OH)D and PTH Levels and Risk of Falling in Older Men and Women in the Boston STOP IT Trial. J Clin Endocrinol Metab. 2022. PMID: 35022738. doi:10.1210/clinem/dgac012

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。